Ostruzione congenita del dotto nasolacrimale
Revisione paritaria di Dr Krishna Vakharia, MRCGPUltimo aggiornamento di Dr Colin Tidy, MRCGPUltimo aggiornamento 21 Dic 2022
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Professionisti Medici
Gli articoli di riferimento professionale sono progettati per essere utilizzati dai professionisti della salute. Sono scritti da medici del Regno Unito e basati su prove di ricerca, linee guida del Regno Unito ed europee. Potresti trovare il Ostruzione del dotto lacrimale nei neonati articolo più utile, o uno dei nostri altri articoli sulla salute.
The nasolacrimal duct usually canalises at eight months of fetal life but there is commonly a delay in this developmental process which can result in residual membrane tissue or stenosis at any level in the nasolacrimal system - from the canaliculi to the extreme end of the nasolacrimal duct underneath the inferior turbinate.
Congenital nasolacrimal duct obstruction (NLDO) is a common condition causing excessive tearing in the first year of life. The incidence of nasolacrimal duct obstruction in early childhood ranges from 5% to 20%.1
Presentazione
Infants present with excessive tearing or mucoid discharge from the eyes due to blockage of the nasolacrimal duct system, which can result in maceration of the skin of the eyelids, sticky eyes, crusting of the eyelids and local infections, such as conjunctivitis.1
Diagnosi differenziale
Diagnosis is usually straightforward - but always consider:
Congenital dacryocystocele (uncommon tense blueish swelling of the lacrimal sac) - acute inflammation occurs commonly and there may be an associated intranasal cyst. Refer to ophthalmology.
Congenital conjunctivitis (ophthalmia neonatorum) or other congiuntivite.
Glaucoma congenito - this is another important paediatric childhood condition that may present with epiphora. Photophobia, a difference in eye size (compare the diameter of the cornea of each eye with a simple desk-top clear ruler) and clouding of the cornea suggest congenital glaucoma which needs urgent ophthalmic assessment.2
Other congenital abnormality - eg, albinismo or aniridia.
Indagini
Fluorescein dye disappearance test may be helpful - a small drop of dye is instilled into both eyes and will normally disappear over five minutes if the duct is patent, and may subsequently be visible in the nostril using blue light.
However, this is usually a clinical diagnosis and using dye is often not necessary.
Gestione3 4
Congenital nasolacrimal duct obstruction often resolves without surgery. Treatment options are either conservative, including observation (or deferred probing), massage of the lacrimal sac, and antibiotics, or probing the nasolacrimal duct to open the membranous obstruction at the distal nasolacrimal duct. Probing may not be successful if the obstruction is due to a bony protrusion of the inferior turbinate into the nasolacrimal duct or when the duct is oedematous due to infection. Potential complications with probing include creation of a false passage and injury to the nasolacrimal duct, canaliculi and puncta, bleeding, laryngospasm, or aspiration. The effects and costs of immediate versus deferred probing are uncertain.1
Conservative
In most cases, simple massaging of the ducts may be enough because of the high rate of spontaneous resolution. Parents should be advised to apply gentle pressure with their finger over the common canaliculus, stroking downwards firmly to raise pressure in the lacrimal sac and encourage opening of the valve. They should perform ten strokes twice daily. They should also be advised to perform regular cleaning of any discharge from the eyelids.5
Use topical antibiotics for any episodes of associated conjunctivitis (ie red conjunctiva as opposed to simple discharge).
In infants with nasolacrimal duct obstruction (NLDO) who are aged between 6 and 10 months, non-surgical management will resolve symptoms within six months in over half of cases.6
Chirurgico
Current guidelines are for children with persistent obstruction beyond 1 year of age to be referred for probing as a first-line interventional therapy.5 This is usually carried out under a brief general anaesthetic as a day case. However, the optimal timing for probing still remains controversial.7 Although there is still a high possibility of spontaneous resolution after 1 year of age, there is actually a reduction in success rates for probing with increasing age.
Surgical treatment is rarely considered before 6 months of age.6
One study found that probing was successful in 75% of eyes overall. The procedure was less successful in eyes of children with bilateral NLDO compared with unilateral NLDO.8
If symptoms persist after probing then the procedure can be repeated, usually with placement of a silicone stent to hold the passage open whilst it settles from the surgery.9 This remains in place for several months before removal, again usually with a brief general anaesthetic. Occasionally a dacryocystorhinostomy (DCR) procedure is required.
Complicazioni
Congiuntivite is the most common complication. This can be managed with simple topical antibiotics. The baby may also be born with - or develop - a dacryocystocele (mucocele) whereby fluid (eg, amniotic fluid) enters the sac and is retained by the non-patent duct. This may lead to acute dacryocystitis.
The risks of probing include:
Failure - the risks of this increase exponentially with age and number of probings.
Creation of a false passage.
Bleeding (rare).
Aggiornamenti esclusivi per i professionisti sanitari
Rimani informato con gli ultimi aggiornamenti clinici, approfondimenti professionali e linee guida basate su evidenze. La newsletter Patient Pro seleziona contenuti essenziali per i professionisti sanitari—consegnati direttamente nella tua casella di posta.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.
Ulteriori letture e riferimenti
- Petris C, Liu D; Esame con sondaggio per l'ostruzione congenita del dotto nasolacrimale. Cochrane Database Syst Rev. 2017 Jul 12;7:CD011109. doi: 10.1002/14651858.CD011109.pub2.
- Moore DB, Tomkins O, Ben-Zion I; A review of primary congenital glaucoma in the developing world. Surv Ophthalmol. 2013 May-Jun;58(3):278-85. doi: 10.1016/j.survophthal.2012.11.003. Epub 2013 Mar 5.
- Vagge A, Ferro Desideri L, Nucci P, et al; Ostruzione Congenita del Dotto Nasolacrimale (CNLDO): Una Revisione. Malattie. 22 ottobre 2018; 6(4). pii: diseases6040096. doi: 10.3390/diseases6040096.
- Avram E; Approfondimenti nel trattamento dell'ostruzione congenita del dotto nasolacrimale. Rom J Ophthalmol. Apr-Giu 2017;61(2):101-106. doi: 10.22336/rjo.2017.19.
- Ostruzione del dotto nasolacrimale (disfunzione del drenaggio nasolacrimale); College degli optometristi, marzo 2016
- Risoluzione dell'ostruzione congenita del dotto nasolacrimale con trattamento non chirurgico; Arch Ophthalmol. 2012 Giu;130(6):730-4. doi: 10.1001/archophthalmol.2012.454.
- Takahashi Y, Kakizaki H, Chan WO, et al; Gestione dell'ostruzione congenita del dotto nasolacrimale. Acta Ophthalmol. 2009 Jul 21.
- Miller AM, Chandler DL, Repka MX, et al; Office probing for treatment of nasolacrimal duct obstruction in infants. J AAPOS. 2014 Feb;18(1):26-30. doi: 10.1016/j.jaapos.2013.10.016.
- Memon MN, Siddiqui SN, Arshad M, et al; Nasolacrimal duct obstruction in children: outcome of primary intubation. J Pak Med Assoc. 2012 Dec;62(12):1329-32.
Informazioni sul recensoreVisualizza il profilo completo

Dr Krishna Vakharia, MRCGP
Direttore Sanitario per la Salute, Optum UK
MBChB, MRCGP(2013), BMedSci (hons), DFSRH, DRCOG, PGDipDerm (Distn)
La Dott.ssa Krishna Vakharia è un medico di base del NHS. È anche un'esaminatrice regolare per il Diploma post-laurea in Dermatologia Pratica presso l'Università di Cardiff, oltre ad essere il Direttore Medico per la salute presso Optum UK.
Altro in pediatria
- Disturbi dello spettro autistico
- Sindrome di Bowen-Armstrong
- Problemi comportamentali comuni nei bambini
- Allergia alimentare e intolleranza alimentare
- Malattia emolitica del feto e del neonato
- Sindrome da distress respiratorio infantile
- Intolleranza al lattosio
- Sindrome di Lennox-Gastaut
- Malattia di McArdle
- Vaccinazione contro morbillo, parotite e rosolia (MMR)
- Neuroblastomi
- Prescrizioni per bambini
- Ipoplasia polmonare
- Febbre reumatica
- Problemi di sonno nei bambini
- Piccolo per l'età gestazionale
- Emergenze chirurgiche nell'infanzia
- torsione del testicolo
- Sindrome di Tourette e altri disturbi da tic
- Sindrome di West


